secwatch.observer — SEC 8-K summary
======================================

Issuer:     Harmony Biosciences Holdings, Inc. (HRMY)
CIK:        0001802665
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0001558370-24-008734
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Harmony Biosciences shareholders elect all three Class I directors and ratify Deloitte as auditor
--------------------------------------------------------------------------------

- Jeffrey S. Aronin, R. Mark Graf, and Jeffrey M. Dayno elected as Class I directors with votes ranging from 18.3M to 20.6M for.
- Ratification of Deloitte & Touche LLP as independent auditor for 2024 passed with 40.2M votes for, 495k against, 12,722 abstain.
- Approximately 40.7M shares (quorum) represented at the 2024 Annual Meeting held May 29, 2024.
- All director nominees will serve until the 2027 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802665/000155837024008734/0001558370-24-008734-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802665/000155837024008734/hrmy-20240529x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-008734

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer